Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Industry Recognition

31 Jan 2006 07:02

Sopheon PLC31 January 2006 Embargoed Release: 07:00hrs Tuesday 31st January 2006 Sopheon Plc ('Sopheon' or the 'Company') Leading IT Market Research Firm Cites Sopheon As First-Mover In Taking Advantage of Major Market Trend New Report Says Company Well-Positioned to Benefit From Convergence of Product Life Cycle and Portfolio Management Solutions Sopheon Plc, the international software and services company, announces todaythat global IT research and advisory firm IDC has published a profile analyzingSopheon and its flagship Accolade process and product portfolio managementsystem. The report credits Sopheon with early recognition of the convergence ofproduct life cycle management (PLM) and project portfolio management (PPM)solutions and taking effective action to capitalize on this trend, which IDCcharacterizes as a major, new market force. (Source: IDC, "Sopheon's AccoladeBreaking out in PLM and Portfolio Management Convergence," Doc #34274.) In an IDC Product Flash, analysts Evan Quinn and Gisela Wilson examine Sopheon'smarket position and the evolution of its flagship offering. From the analysts'perspective, Accolade's functional focus on improving the product developmentprocess, including recent enhancements to the solution, has separated it fromtraditional project portfolio management software and is positively impactingSopheon's business outlook. The report observes that Sopheon seems "particularly well positioned to ride thePLM/PPM convergence trend given its differentiated approach." Earmarks of thatapproach, according to IDC's analysis, include built-in support for the widelyused Stage-Gate(R) product development process framework; portals and analyticstargeted for process industries; integration with Microsoft(R) Project; andstrong portfolio management features. The commentary points to Sopheon'sexpanding sales pipeline, increasing deal size and its stepped-up pursuit ofindirect channel sales partnerships as validation that the company is movinginto a new phase of growth. "Sopheon stands out as a first mover in PLM/PPM convergence," the reportconcludes, "and possesses a position of leverage in Microsoft's businessapplication partnership community. Accolade is ahead of many of its moreestablished competitors in terms of how to leverage collaboration, portal, andcontent technologies for innovation management." "Generic project management tools can provide great value operationally," saidAndy Michuda, chief executive officer of Sopheon, "But they don't address theneeds of corporate executives for information that can help them make strategicproduct-development decisions. There's a growing body of evidence that one ofthe most important characteristics separating innovation leaders from the packis that they put in place a strong product innovation process and support itwith superior project management skills. Accolade enables organizations toquickly develop these capabilities as a sustainable competitive advantage. Oursolution was built from the ground up to manage projects within the businesscontext of the new product development process. And it has demonstrated that itcan produce break-through results. Being recognized as a "first-mover" in thisemerging market of applying project management best-practices to the productlife cycle management process is strong validation of our unique application andstrategic focus. Having this recognition come from one of the world's topindependent IT research and advisory firms is especially affirming." Sopheon Accolade(R) is a registered trademark of Sopheon plc. Stage-Gate(R) is a registered trademark of the Product Development Institute. Microsoft(R) is a registered trademark of Microsoft Corporation.All other trademarks and registered trademarks are the soleproperty of their respective owners. About Sopheon Sopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade(R) product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevant contentto healthcare and engineering professionals to enable effective compliance withprotocols, standards and regulations. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.